| MeSH term | MeSH ID | Detail |
|---|---|---|
| Bacterial Infections | D001424 | 21 associated lipids |
| Pain | D010146 | 64 associated lipids |
| Lupus Erythematosus, Systemic | D008180 | 43 associated lipids |
| Stomach Diseases | D013272 | 7 associated lipids |
| Lung Diseases | D008171 | 37 associated lipids |
| Lung Neoplasms | D008175 | 171 associated lipids |
| Skin Neoplasms | D012878 | 12 associated lipids |
| Colitis | D003092 | 69 associated lipids |
| Leishmaniasis, Visceral | D007898 | 13 associated lipids |
| Diabetes Mellitus, Type 1 | D003922 | 56 associated lipids |
clarithromycin
clarithromycin is a lipid of Polyketides (PK) class. Clarithromycin is associated with abnormalities such as Helicobacter Pylori Infection, Infection, Coinfection, Gastritis and Peptic Ulcer. The involved functions are known as Point Mutation, Increased Sensitivy, Bacterial resistance, urease activity and Mutation. Clarithromycin often locates in Blood, Gastric mucosa, Biopsy sample, Respiratory System and Entire gastrointestinal tract. The associated genes with clarithromycin are Genes, rRNA, rRNA Operon, Genome, HM13 gene and GDF15 gene. The related lipids are 9,11-linoleic acid, Steroids, Lysophosphatidylcholines, Lipopolysaccharides and 4-hydroxycholesterol. The related experimental models are Mouse Model, Knock-out and Experimental Pneumococcal Meningitis.
Cross Reference
Introduction
To understand associated biological information of clarithromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with clarithromycin?
clarithromycin is suspected in Infection, Helicobacter Pylori Infection, Pneumonia, Respiratory Tract Infections, PARKINSON DISEASE, LATE-ONSET, Community acquired pneumonia and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (63)
- J. Antimicrob. Chemother. (56)
- J. Clin. Microbiol. (39)
- Others (258)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with clarithromycin
PubChem Associated disorders and diseases
What pathways are associated with clarithromycin
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with clarithromycin?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
- J. Antimicrob. Chemother. (25)
- Antimicrob. Agents Chemother. (20)
- J. Clin. Microbiol. (9)
- Others (66)
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with clarithromycin?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with clarithromycin?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with clarithromycin?
Related references are published most in these journals:
- J. Antimicrob. Chemother. (20)
- Antimicrob. Agents Chemother. (17)
- J. Clin. Microbiol. (13)
- Others (57)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with clarithromycin?
Mouse Model
Mouse Model are used in the study 'Inflammation provoked by Mycoplasma pneumoniae extract: implications for combination treatment with clarithromycin and dexamethasone.' (Hirao S et al., 2011), Mouse Model are used in the study 'Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers.' (Hafner R et al., 1998), Mouse Model are used in the study 'Clarithromycin attenuates mastectomy-induced acute inflammatory response.' (Chow LW et al., 2000) and Mouse Model are used in the study 'In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa.' (Bui KQ et al., 2000).
Knock-out
Knock-out are used in the study 'Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38).' (Nash KA, 2003).
Experimental Pneumococcal Meningitis
Experimental Pneumococcal Meningitis are used in the study 'Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid.' (Maniu CV et al., 2001).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with clarithromycin
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Schrock CG | Clarithromycin vs penicillin in the treatment of streptococcal pharyngitis. | 1992 | J Fam Pract | pmid:1453146 |
| Masuda H et al. | Necessity of multiple gastric biopsies from different sites for detection of clarithromycin-resistant Helicobacter pylori strains. | 2003 | Scand. J. Gastroenterol. | pmid:14531530 |
| Lascols C et al. | Fast and accurate quantitative detection of Helicobacter pylori and identification of clarithromycin resistance mutations in H. pylori isolates from gastric biopsy specimens by real-time PCR. | 2003 | J. Clin. Microbiol. | pmid:14532184 |
| Choi BK et al. | [A prospective study on rabeprazole-based triple therapy for Helicobacter pylori eradication in patients with peptic ulcer]. | 2003 | Korean J Gastroenterol | pmid:14532713 |
| Kim N et al. | [Retreatment of Helicobacter pylori infection with triple therapy after initial treatment failure]. | 2003 | Korean J Gastroenterol | pmid:14532741 |
| RodrÃguez W et al. | [Omeprazole, amoxicillin and clarithromycin in the treatment of helicobacterpylori, in 7 and 10-day regimens]. | 2003 Jul-Sep | Rev Gastroenterol Peru | pmid:14532918 |
| Veldhuyzen van Zanten S et al. | A randomized trial comparing seven-day ranitidine bismuth citrate and clarithromycin dual therapy to seven-day omeprazole, clarithromycin and amoxicillin triple therapy for the eradication of Helicobacter pylori. | 2003 | Can. J. Gastroenterol. | pmid:14532926 |
| Eisig JN et al. | The impact of Helicobacter pylori resistance on the efficacy of a short course pantoprazole based triple therapy. | 2003 Jan-Mar | Arq Gastroenterol | pmid:14534667 |
| Lamouliatte H et al. | Second-line treatment for failure to eradicate Helicobacter pylori: a randomized trial comparing four treatment strategies. | 2003 | Aliment. Pharmacol. Ther. | pmid:14535872 |
| Miehlke S et al. | Esomeprazole-based one-week triple therapy with clarithromycin and metronidazole is effective in eradicating Helicobacter pylori in the absence of antimicrobial resistance. | 2003 | Aliment. Pharmacol. Ther. | pmid:14535873 |
| Perri F et al. | Randomized study of different 'second-line' therapies for Helicobacter pylori infection after failure of the standard 'Maastricht triple therapy'. | 2003 | Aliment. Pharmacol. Ther. | pmid:14535875 |
| Neri M et al. | Role of antibiotic sensitivity testing before first-line Helicobacter pylori eradication treatments. | 2003 | Aliment. Pharmacol. Ther. | pmid:14535876 |
| Lai KC et al. | Lansoprazole reduces ulcer relapse after eradication of Helicobacter pylori in nonsteroidal anti-inflammatory drug users--a randomized trial. | 2003 | Aliment. Pharmacol. Ther. | pmid:14535877 |
| Chang FY et al. | Effect of Helicobacter pylori eradicated therapy on water gastric emptying in patients with active duodenal ulcer. | 2003 | J. Gastroenterol. Hepatol. | pmid:14535981 |
| Yajko DM | In vitro activity of antimicrobial agents against the Mycobacterium avium complex inside macrophages from HIV1-infected individuals: the link to clinical response to treatment? | 1992 | Res. Microbiol. | pmid:1455069 |
| Yamasawa H et al. | Macrolides inhibit epithelial cell-mediated neutrophil survival by modulating granulocyte macrophage colony-stimulating factor release. | 2004 | Am. J. Respir. Cell Mol. Biol. | pmid:14551160 |
| Field SK and Cowie RL | Treatment of Mycobacterium avium-intracellulare complex lung disease with a macrolide, ethambutol, and clofazimine. | 2003 | Chest | pmid:14555583 |
| Griffith DE et al. | Thrice-weekly clarithromycin-containing regimen for treatment of Mycobacterium kansasii lung disease: results of a preliminary study. | 2003 | Clin. Infect. Dis. | pmid:14557961 |
| Benson CA et al. | A prospective, randomized trial examining the efficacy and safety of clarithromycin in combination with ethambutol, rifabutin, or both for the treatment of disseminated Mycobacterium avium complex disease in persons with acquired immunodeficiency syndrome. | 2003 | Clin. Infect. Dis. | pmid:14557969 |
| Khan S et al. | Cefaclor AF vs Clarithromycin in acute exacerbation of chronic bronchitis (B3M-PK-AJBG). | 2003 | J Pak Med Assoc | pmid:14558738 |
| Lode H et al. | Sequential IV/PO moxifloxacin treatment of patients with severe community-acquired pneumonia. | 2003 | Respir Med | pmid:14561021 |
| Chaisson R | Clarithromycin is effective against M. avium complex in AIDS. | 1992 | Am Fam Physician | pmid:1456199 |
| Nishimura T et al. | [Clinical efficacy and bacteriological studies of clarithromycin and cefdinir against group A beta-hemolytic streptococcal tonsillopharyngitis]. | 2003 | Jpn J Antibiot | pmid:14567252 |
| Parente F et al. | Treatment options for patients with Helicobacter pylori infection resistant to one or more eradication attempts. | 2003 | Dig Liver Dis | pmid:14567454 |
| Toracchio S and Marzio L | Primary and secondary antibiotic resistance of Helicobacter pylori strains isolated in central Italy during the years 1998-2002. | 2003 | Dig Liver Dis | pmid:14567457 |
| Schouwenberg BJ and Deinum J | Acute pancreatitis after a course of clarithromycin. | 2003 | Neth J Med | pmid:14567525 |
| Cultrara A et al. | The role of Chlamydia pneumoniae infection in children with chronic sinusitis. | 2003 | Arch. Otolaryngol. Head Neck Surg. | pmid:14568794 |
| Yanagawa Y et al. | A combination effect of epigallocatechin gallate, a major compound of green tea catechins, with antibiotics on Helicobacter pylori growth in vitro. | 2003 | Curr. Microbiol. | pmid:14570277 |
| Furuta T et al. | Evidence for the validity of cortisol 6 beta-hydroxylation clearance as a new index for in vivo cytochrome P450 3A phenotyping in humans. | 2003 | Drug Metab. Dispos. | pmid:14570755 |
| Hsu CC et al. | One-week low-dose triple therapy without anti-acid treatment has sufficient efficacy on Helicobacter pylori eradication and ulcer healing. | 2003 Sep-Oct | Hepatogastroenterology | pmid:14571829 |
| Callaghan R and Allen M | Mycobacterium malmoense infection of the knee. | 2003 | Ann. Rheum. Dis. | pmid:14583565 |
| Deetz TR et al. | Successful treatment of Balamuthia amoebic encephalitis: presentation of 2 cases. | 2003 | Clin. Infect. Dis. | pmid:14583863 |
| Donta ST | Macrolide therapy of chronic Lyme Disease. | 2003 | Med. Sci. Monit. | pmid:14586290 |
| Watanabe H et al. | Improvement in gastric histology following Helicobacter pylori eradication therapy in Japanese peptic ulcer patients. | 2003 Sep-Oct | J. Int. Med. Res. | pmid:14587302 |
| Soto G et al. | Helicobacter pylori reinfection is common in Peruvian adults after antibiotic eradication therapy. | 2003 | J. Infect. Dis. | pmid:14593583 |
| Teuber M et al. | Molecular structure and evolution of the conjugative multiresistance plasmid pRE25 of Enterococcus faecalis isolated from a raw-fermented sausage. | 2003 | Int. J. Food Microbiol. | pmid:14597005 |
| Stock I et al. | Natural antibiotic susceptibility of Ewingella americana strains. | 2003 | J Chemother | pmid:14598935 |
| Yajima T et al. | Optimum heat treatment conditions for masking the bitterness of the clarithromycin wax matrix. | 2003 | Chem. Pharm. Bull. | pmid:14600362 |
| Tanigake A et al. | The bitterness intensity of clarithromycin evaluated by a taste sensor. | 2003 | Chem. Pharm. Bull. | pmid:14600366 |
| Küçükbasmaci O et al. | In vitro activity of telithromycin compared with macrolides and fluoroquinolones against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis. | 2003 | Int. J. Antimicrob. Agents | pmid:14602368 |
| [Acute exacerbated chronic bronchitis. Antibiotics in comparison]. | 2003 | MMW Fortschr Med | pmid:14603610 | |
| Bhaloo S and Prasad GV | Severe reduction in tacrolimus levels with rifampin despite multiple cytochrome P450 inhibitors: a case report. | 2003 | Transplant. Proc. | pmid:14611983 |
| O'Brien SG et al. | Effects of imatinib mesylate (STI571, Glivec) on the pharmacokinetics of simvastatin, a cytochrome p450 3A4 substrate, in patients with chronic myeloid leukaemia. | 2003 | Br. J. Cancer | pmid:14612892 |
| Campos J et al. | Antibiotic resistance and clinical significance of Haemophilus influenzae type f. | 2003 | J. Antimicrob. Chemother. | pmid:14613949 |
| Kositchaiwat C et al. | Low and high doses of rabeprazole vs. omeprazole for cure of Helicobacter pylori infection. | 2003 | Aliment. Pharmacol. Ther. | pmid:14616168 |
| Romero-Gómez M et al. | Three-day intravenous triple therapy is not effective for the eradication of Helicobacter pylori infection in patients with bleeding gastro-duodenal ulcer. | 2003 | Aliment. Pharmacol. Ther. | pmid:14616169 |
| den Broeder AA et al. | Disseminated Mycobacterium gordonae infection in a renal transplant recipient. | 2003 | Transpl Infect Dis | pmid:14617305 |
| De Freitas S et al. | A case of rheumatic fever. | 2003 | Heart | pmid:14617546 |
| Neuhann HF et al. | Efficacy of different antibiotic regimens for eradication treatment of Helicobacter pylori infection in peptic ulcer disease in Tanzanian patients. | 2003 | Trop Doct | pmid:14620428 |
| Borody TJ and Ashman O | Lactoferrin: milking ulcers? | 2003 | Dig Liver Dis | pmid:14620616 |
| Di Mario F et al. | Use of bovine lactoferrin for Helicobacter pylori eradication. | 2003 | Dig Liver Dis | pmid:14620619 |
| Watanabe Y et al. | Levofloxacin based triple therapy as a second-line treatment after failure of helicobacter pylori eradication with standard triple therapy. | 2003 | Dig Liver Dis | pmid:14620620 |
| Olmos MartÃnez JM et al. | [Definitive treatment of Helicobacter pylori infection in MALT low degree gastric lymphoma]. | 2003 | Rev Clin Esp | pmid:14622518 |
| Muhlestein JB | Antibiotic treatment of atherosclerosis. | 2003 | Curr. Opin. Lipidol. | pmid:14624138 |
| Herszényi L | [Eradication of Helicobacter pylori]. | 2003 | Orv Hetil | pmid:14626641 |
| Migneco A et al. | Eradication of Helicobacter pylori infection improves blood pressure values in patients affected by hypertension. | 2003 | Helicobacter | pmid:14632672 |
| Bochenek WJ et al. | Eradication of Helicobacter pylori by 7-day triple-therapy regimens combining pantoprazole with clarithromycin, metronidazole, or amoxicillin in patients with peptic ulcer disease: results of two double-blind, randomized studies. | 2003 | Helicobacter | pmid:14632678 |
| Ribeiro ML et al. | Mutations in the 23S rRNA gene are associated with clarithromycin resistance in Helicobacter pylori isolates in Brazil. | 2003 | Ann. Clin. Microbiol. Antimicrob. | pmid:14633281 |
| Take S et al. | Interleukin-1beta genetic polymorphism influences the effect of cytochrome P 2C19 genotype on the cure rate of 1-week triple therapy for Helicobacter pylori infection. | 2003 | Am. J. Gastroenterol. | pmid:14638340 |
| Ohe M and Kohno M | [Three cases of idiopathic thrombocytopenic purpura showing an increase in the platelet count following clarithromycin treatment]. | 2003 | Rinsho Ketsueki | pmid:14639954 |
| Zou J et al. | [Laboratory and clinical study of levofloxacin against Helicobacter pylori]. | 2003 | Zhonghua Yi Xue Za Zhi | pmid:14642083 |
| GarcÃa-GarcÃa A et al. | New agents active against Mycobacterium avium complex selected by molecular topology: a virtual screening method. | 2004 | J. Antimicrob. Chemother. | pmid:14645324 |
| Arnheim K | [Digitalis -- poisoning, myopathy, ergotism.... When antibiotic and associated therapy become dangerous mixture]. | 2003 | MMW Fortschr Med | pmid:14649064 |
| Nanda S et al. | Multidrug-resistant cutaneous tuberculosis: response to therapy. | 2003 Nov-Dec | Pediatr Dermatol | pmid:14651584 |
| Korppi M | Community-acquired pneumonia in children: issues in optimizing antibacterial treatment. | 2003 | Paediatr Drugs | pmid:14658923 |
| Croom KF and Goa KL | Levofloxacin: a review of its use in the treatment of bacterial infections in the United States. | 2003 | Drugs | pmid:14664657 |
| Alvirez-Freites E et al. | In vitro susceptibility of nocardia species to cethromycin, clarithromycin and amikacin. | 2004 | Eur. J. Clin. Microbiol. Infect. Dis. | pmid:14666401 |
| Alberts JH and Boyd AS | Nocardia otitidiscaviarum: an unusual Nocardia species causing a primary lymphocutaneous infectious process in a mildly immunosuppressed patient. | 2002 Sep-Oct | Skinmed | pmid:14673241 |
| Gambaro C et al. | Comparable Helicobacter pylori eradication rates obtained with 4- and 7-day rabeprazole-based triple therapy: a preliminary study. | 2003 | Dig Liver Dis | pmid:14674665 |
| Stanat SJ et al. | Characterization of the inhibitory effects of erythromycin and clarithromycin on the HERG potassium channel. | 2003 | Mol. Cell. Biochem. | pmid:14674677 |
| Thyagarajan SP et al. | Geographical difference in antimicrobial resistance pattern of Helicobacter pylori clinical isolates from Indian patients: Multicentric study. | 2003 | J. Gastroenterol. Hepatol. | pmid:14675265 |
| Welge-Luessen A and Wolfensberger M | Reversible anosmia after amikacin therapy. | 2003 | Arch. Otolaryngol. Head Neck Surg. | pmid:14676161 |
| Baz K et al. | Fatal aplastic anaemia in a patient with clarithromycin-induced toxic epidermal necrolysis. | 2004 | J Eur Acad Dermatol Venereol | pmid:14678548 |
| Sandrini A et al. | Diffuse panbronchiolitis in a Caucasian man in Canada. | 2003 Nov-Dec | Can. Respir. J. | pmid:14679410 |
| Hirata T et al. | [Therapeutic effect of macrolide antibiotics on surgical inflammatory stress following pulmonary surgical procedures]. | 2003 | Jpn J Antibiot | pmid:14679739 |
| Hino M et al. | [Influence of long-term macrolide therapy for chronic inflammation of respiratory tract on concurrent helicobacter pylori infection of stomach]. | 2003 | Jpn J Antibiot | pmid:14679746 |
| Nohata K et al. | [Effect of clarithromycin on pathogenic factors in Helicobacter pylori]. | 2003 | Jpn J Antibiot | pmid:14679747 |
| Yanagihara K et al. | [Effect of macrolide antibiotics on secretion of MUC5AC in murine model of diffuse panbronchiolitis and related diseases]. | 2003 | Jpn J Antibiot | pmid:14679750 |
| Shiroki K | [Anti-influenza mechanism of macrolide antibiotics inducing airway IL-12 production in murine influenza model ]. | 2003 | Jpn J Antibiot | pmid:14679751 |
| Ushikai M et al. | [Effect of macrolide antibiotics on VEGF production in nasal mucosa fibroblasts cultured under hypoxic conditions]. | 2003 | Jpn J Antibiot | pmid:14679755 |
| Kikuchi T et al. | [Suppressive mechanism of clarithromycin on lipopolysaccharide-induced IL-8 production in human monocytes by mediating AP-1 and NF-kappaB]. | 2003 | Jpn J Antibiot | pmid:14679759 |
| Watanabe T et al. | [Combined therapy for patients with chronic paranasal sinusitis using a macrolide antibiotic and YAMIK catheter]. | 2003 | Jpn J Antibiot | pmid:14679773 |
| Kataoka S et al. | [Combined drug therapy for patients with intractable paranasal sinusitis complicating allergic rhinitis]. | 2003 | Jpn J Antibiot | pmid:14679774 |
| Kuipers EJ et al. | Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial. | 2004 | Gut | pmid:14684569 |
| Fischbach W et al. | Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series. | 2004 | Gut | pmid:14684573 |
| Inoue K et al. | Effects of eight antibacterial agents on cell survival and expression of epithelial-cell- or cell-adhesion-related genes in human gingival epithelial cells. | 2004 | J. Periodont. Res. | pmid:14687228 |
| Ojetti V et al. | Beta-lactamase inhibitor enhances Helicobacter pylori eradication rate. | 2004 | J. Intern. Med. | pmid:14687248 |
| Fukui H et al. | Effects of Helicobacter pylori infection on the link between regenerating gene expression and serum gastrin levels in Mongolian gerbils. | 2003 | Lab. Invest. | pmid:14691296 |
| Giamarellos-Bourboulis EJ et al. | Immunomodulatory clarithromycin treatment of experimental sepsis and acute pyelonephritis caused by multidrug-resistant Pseudomonas aeruginosa. | 2004 | Antimicrob. Agents Chemother. | pmid:14693524 |
| Lee SB et al. | Efficacy of triple therapy with rabeprazole for Helicobacter pylori infection in relation to CYP2C19 genotype. | 2003 | Korean J Gastroenterol | pmid:14695703 |
| Omura S et al. | [Research and development of clarithromycin]. | 1992 | Yakugaku Zasshi | pmid:1469609 |
| Furuta T et al. | High-dose rabeprazole/amoxicillin therapy as the second-line regimen after failure to eradicate H. pylori by triple therapy with the usual doses of a proton pump inhibitor, clarithromycin and amoxicillin. | 2003 Nov-Dec | Hepatogastroenterology | pmid:14696516 |
| MarÃn-Casanova P et al. | Endophthalmitis caused by Mycobacterium abscessus. | 2003 Nov-Dec | Eur J Ophthalmol | pmid:14700104 |
| Rubio-Terrés C et al. | [Pharmacoeconomic analysis of community-acquired pneumonia treatment with telithromycin or clarithromycin]. | 2003 | Rev Esp Quimioter | pmid:14702121 |
| Abad-Santos F et al. | [Meta-analysis of clarithromycin compared with other antimicrobial drugs in the treatment of upper respiratory tract infections]. | 2003 | Rev Esp Quimioter | pmid:14702124 |
| Barry A et al. | Preparation of stock solutions of macrolide and ketolide compounds for antimicrobial susceptibility tests. | 2004 | Clin. Microbiol. Infect. | pmid:14706092 |
| Isakov VA et al. | [Results of an open multicenter study of the efficiency of one-week anti-helicobacter therapy using omeprazole, clarithromycin, and amoxicillin in patients with duodenal peptic ulcer]. | 2003 | Ter. Arkh. | pmid:14708448 |
| Halkic N et al. | Recurrent cytomegalovirus disease, visceral leishmaniosis, and Legionella pneumonia after liver transplantation: a case report. | 2004 | Can J Anaesth | pmid:14709468 |
| Brinkman JM et al. | Non-operative treatment for perforated gastro-duodenal peptic ulcer in Duchenne muscular dystrophy: a case report. | 2004 | BMC Surg | pmid:14713321 |
| Uchida T et al. | Evaluation of the bitterness of antibiotics using a taste sensor. | 2003 | J. Pharm. Pharmacol. | pmid:14713358 |